CRON earnings date and last-quarter result: last quarter in line, P/E -1264.73. Updated 2026-07-23.
Cronos Group (CRON) Research Hub
Cronos Group (CRON) trades on NASDAQ, CA in the Healthcare (Drug Manufacturers - Specialty & Generic) sector. As of 2026-10-26, shares last closed at 3.31 USD (-1.19%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1264.73, market cap 1.05B. This hub links to the full technical, earnings and options research available for CRON.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Drug Manufacturers - Specialty & Generic) |
|---|---|
| Exchange | NASDAQ, CA |
| Last close | 3.31 USD (-1.19%) |
| 52-week range | 2.6 USD – 3.58 USD |
| Trend regime | Range |
| 14-day RSI | 51.7 (Neutral) |
| Trailing P/E | -1264.73 |
| Market cap | 1.05B |
| Dividend yield | 0.00% |
Available research for CRON
Covered Call on CRON: how it works, illustrative setup around the real 3.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRON: how it works, illustrative setup around the real 3.31 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRON: how it works, illustrative setup around the real 3.31 USD price, max profit/loss, breakeven and when to use it. Educational.
CRON technical analysis: range, last 3.31 USD, RSI 51.7, 52w range 2.6 USD–3.58 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CRON in?
Cronos Group (CRON) is classified under Healthcare (Drug Manufacturers - Specialty & Generic), listed on NASDAQ, CA.
Is CRON in an uptrend or downtrend?
As of 2026-10-26, CRON is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRON's trailing P/E ratio?
CRON's trailing P/E is -1264.73, with a market cap of 1.05B. See the earnings research page for full valuation detail.